The report concluded that, in addition to greater incidence, more severe stroke, and greater mortality, racial/ethnic minorities are less likely to receive tissue plasminogen activator (tPA) and diagnostic procedures critical to early stroke diagnosis and management. This evidence concerns the gene PLAT and Stroke.